Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment options in benign prostatic hypertrophy.

N N Stone1

  • 1Mount Sinai School of Medicine, New York.

Hospital Practice (Office Ed.)
|October 30, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy.

The Journal of urology·2005
Same author

Serum interleukin-8 is elevated in men with prostate cancer and bone metastases.

Technology in cancer research & treatment·2004
Same author

Brachytherapy or radical prostatectomy: is there a preferred method for treating localized prostate cancer?

BJU international·2003
Same author

Putative protein markers in the sera of men with prostatic neoplasms.

BJU international·2003
Same author

Prevalence and natural history of urinary symptoms in a longitudinal national prostate cancer screening (community-based) study.

Prostate cancer and prostatic diseases·2002
Same author

Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer.

Prostate cancer and prostatic diseases·2002
Same journal

Oral contraceptives: an update.

Hospital practice (Office ed.)·1995
Same journal

Progress in the immunogenetics of rheumatoid arthritis.

Hospital practice (Office ed.)·1995
Same journal

An asymptomatic lung nodule in an elderly woman with joint pain.

Hospital practice (Office ed.)·1995
Same journal

Defusing status epilepticus.

Hospital practice (Office ed.)·1995
Same journal

Persistent fever and flank discomfort in a young woman.

Hospital practice (Office ed.)·1995
Same journal

New thoughts on attention-deficit/hyperactivity disorder.

Hospital practice (Office ed.)·1995
See all related articles

Surgery is the primary treatment for progressive urinary symptoms. However, medications like antiandrogens, 5 alpha-reductase inhibitors, and alpha-adrenergic antagonists can be effective for select patients.

Area of Science:

  • Urology
  • Surgical Oncology

Background:

  • Progressive urinary symptoms necessitate treatment.
  • Surgical intervention is often the initial approach.

Observation:

  • Patient selection is crucial for treatment efficacy.
  • Various medical therapies exist as alternatives or adjuncts to surgery.

Findings:

  • Surgery is the established first-line treatment for worsening urinary symptoms.
  • Medical options including antiandrogens, 5 alpha-reductase inhibitors, and alpha-adrenergic antagonists offer viable alternatives for specific patient groups.

Implications:

  • Understanding treatment options beyond surgery is vital for comprehensive patient care.
  • Personalized treatment strategies can improve outcomes for urinary symptom management.

Related Experiment Videos